P hosphatidyl-myo-inositol mannosides (PIMs) 5 are major components of the outer leaflet of the plasma membrane of mycobacteria and form the glycolipid core of the cell wall associated lipids lipomannan (LM) and lipoarabinomannan (LAM) (1) . These glycolipids, together with many other lipids that are unique to mycobacteria (reviewed in Refs. 1 and 2), form the foundation of the mycobacterial cell envelope and provide a special lipid barrier that is responsible for the high resistance to external factors, such as cytotoxic oxygen radicals that are generated in the human macrophage upon infection.
In addition to their structural role in the cell envelope, many of these lipids are potent immunomodulators. LAM is a virulence factor that not only scavenges toxic oxygen-free radicals (3), but also inhibits IFN-␥-mediated activation of macrophages (4) . Furthermore, LAM, LM, and PIM can all induce transcription of cytokine mRNA and elicit cytokine production, which indicates that most of their biological activity is associated with the PIM core, rather than with the complex carbohydrate cap (5) . PIMs and LAM can be taken up directly by the mannose receptor (CD206) on myeloid dendritic cells (6) and are sorted into endosomes, where lipid transfer proteins and the acidic pH environment promote the loading of these glycolipids onto CD1 molecules for subsequent presentation to T cells (7) .
CD1 receptors are a family of lipid-Ag presenting molecules that are structurally related to peptide-presenting MHC class I molecules. However, in contrast to the MHC-lineage, CD1 proteins are nonpolymorphic and feature a deep and hydrophobic binding groove, ideally suited for binding self-and foreign lipids, glycolipids, lipopeptides and other hydrophobic molecules (8) . In humans, the various CD1 isoforms are divided into group 1 (CD1a, CD1b, CD1c, and CD1e) and group 2 (CD1d) based on sequence similarities (9) , but mice only express group 2 CD1d. Whereas group 1 CD1 are recognized by conventional ␣␤ ϩ or ␥␦ ϩ T cells, the main population of group 2 CD1 molecules activate NKT cells (10) , which express both an ␣␤ ϩ TCR and typical markers, such as NK1.1. NKT cells are important in suppressing tumor growth and in regulating a variety of microbial, allergic and autoimmune conditions by rapidly secreting Th1 and Th2 cytokines (11) .
Murine and human NKT cell populations are heterogeneous, but the majority of NKT cells express TCRs with an invariant ␣-chain (iNKT cells, V ␣ 14-J ␣ 18-V ␤ 8, V ␣ 14-J ␣ 18-V ␤ 7, or V ␣ 14-J ␣ 18-V ␤ 2 in mouse and V ␣ 24-J ␣ 18-V ␤ 11 in human). Various foreign ligands can activate iNKT cells, such as the nonmammalian glycolipid, ␣-galactosylceramide (␣-GalCer) (12) , microbial ␣-glycuronosylceramides (13, 14) (containing either glucuronic acid or galacturonic acid (GalA-GSL)), mycobacterial PIM4 (15), as well as the self-ligand isoglobotrihexosylceramide (iGB3) (16) . Crystal structures of CD1d in complex with ␣-GalCer or GalA-GSL (17) (18) (19) have revealed the exquisite hydrogen-bonding network between the ␣-linked carbohydrate headgroup and CD1d, which has not been seen in any other CD1 complex, including human CD1a-sulfatide (20) , CD1a-lipopeptide (21), CD1b-PI (22), CD1b-glucosemonomycolate (23), or mouse CD1d-phosphatidylcholine (CD1d-PC) (24) .
Mycobacterial PIMs (PIM2, PIM4, and PIM6), and the more complex LAMs induce a complex immune response, some of which are initiated through presentation of these mycobacterial glycolipids by CD1b and CD1d (15, 25, 26) . To address the question of how a natural bacterial Ag, PIM2, is presented by CD1d in comparison to other self-glycerolipids, such as PC, and foreign and self-sphingolipids, such as ␣-GalCer and sulfatide, and how PIM4 is recognized by iNKT cells, we crystallized the complex of synthetic PIM2 bound to mouse CD1d and determined its three-dimensional structure to 2.6-Å resolution.
Materials and Methods

Synthesis of 2,6-(Di-O-␣-D-mannopyranosyl)-1-O-(1Ј,2Ј-di-Ohexadecanoyl-sn-glycero-3Ј-phosphoryl)-D-myo-inositol (PIM2)
A synthetic sample of PIM2 was prepared from 1-O-allyl-3,4,5-tri-O-benzyl-D-myo-inositol (27) that was converted into the advanced intermediate,
inositol, by synthetic methods described elsewhere (28) .
.154 mmol) and triethylammonium 1,2-di-O-hexadecanoyl-sn-glycero-3H-phosphonate (223 mg, 0.304 mmol) were dried by evaporation with pyridine (2 ϫ 5 ml) and redissolved in pyridine (5 ml) under argon. Pivaloyl chloride (230 l, 1.87 mmol) was added and the reaction stirred at room temperature for 50 min under argon when a freshly prepared solution of iodine (150 mg, 0.580 mmol) in pyridine/H 2 O (95/5, 25 ml) was added and the reaction stirred for 30 min. CHCl 3 (100 ml) was added and the mixture stirred for an additional 10 min. The organic layer was washed with Na 2 S 2 O 3 (10% aqueous, 100 ml) and aqueous triethylammonium bicarbonate (1 M, 3 ϫ 40 ml), dried (MgSO 4 ), and concentrated in vacuo to give the crude product, which was purified by chromatography on silica gel. Elution with MeOH/dichoromethane (1/99 to 5/95) afforded the title compound (276 mg, 0.124 mmol, 81%) as an oil. 1 
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Protein expression, purification, and crystallization
Soluble and fully glycosylated mouse CD1d-␤ 2 -microglobulin (␤ 2 M) heterodimeric protein was expressed and purified as described (29) . Synthetic PIM2 was loaded onto CD1d by incubating the protein with a 7-fold molar excess of ligand (3 mg/ml in DMSO) in 100 mM Tris (pH 7.0) buffer for 4 h at 37°C with intermittent agitation. The loading of lipids onto CD1 in exchange against any endogenously acquired lipid during protein expression and preparation was optimized previously using a synthetic negatively charged sulfatide ligand and was determined to be 95% efficient, as judged by native isoelectric focusing gel electrophoresis (29) . We, therefore, followed the same protocol for loading PIM2. It cannot be ruled out that a small fraction of CD1 still contains an endogenous lipid; however, we clearly see additional electron density for the more complex PIM2 headgroup. The loaded CD1d protein was further purified from free lipids and any aggregated protein material by size exclusion chromatography on a Superdex S200 10/300GL (GE Healthcare) in 50 mM HEPES (pH 7.5), 150 mM NaCl. Fractions containing heterodimeric CD1d-␤ 2 M were diluted with 4 vol of deionized H 2 O to obtain a final buffer concentration of 10 mM HEPES (pH 7.5) and 30 mM NaCl and concentrated to 8 mg/ml using centrifugal filter devices (Millipore Ultrafree; 10 kDa nominal molecular mass limit) for crystallization. Crystallization experiments were conducted using the sitting drop vapor diffusion method. The best crystals were obtained by mixing 0.8 l of protein with 0.8 l of precipitant (20% polyethylene glycol 4000, 0.1 M sodium citrate (pH 5.5), 10% (v/v) 2-propanol) and grown for several weeks at 22°C for data collection.
Structure determination
Crystals were flash-cooled at of 100 K in mother liquor containing 25% glycerol. Diffraction data from a single crystal were collected at Beamline 8.2.1 of the Advanced Light Source and processed to 2.6 Å with the DenzoScalepack suite (30) (34) . Water molecules were assigned during refinement in REFMAC using the water ARP module for Ͼ3 peaks in an Fo Ϫ F c map and retained if they satisfied hydrogen-bonding criteria and returned 2Fo Ϫ F c density Ͼ1 after refinement. Starting coordinates for the PIM2 ligand were obtained from the CD1b-PI structure (1GZQ) and modified accordingly, using the molecular modeling system INSIGHT II (Accelrys). The PIM2 library for REFMAC (35) was created using the Dundee PRODRG2 server (36) . Final refinement steps were performed using the translation, libration, and screw rotation displacement procedure in REFMAC (37) with a total of three anisotropic domains (␣1-␣3 domains and ␤ 2 M) and resulted in improved electron density maps for the glycolipid ligand and an additional drop in R free . The higher than usual R sym (14.3%) is mainly due to the weak intensity of the overall diffraction data (I/ 7.9) from a very thin needle-like crystal. However, the electron density maps were clearly interpretable and the structure refinement was straightforward. The CD1d-PIM2 structure has a final R cryst ϭ 21.2% and R free ϭ 28.0%, and the quality of the model (Table I) was excellent as assessed with the program Molprobity (38) .
Structure presentation
The program Pymol (͗http://pymol.sourceforge.net/͘) was used to prepare all of the figures. The PDB2PQR server (39) and the program APBS (40) were used to calculate the electrostatic surface potentials. The Chemdraw program was used to prepare all chemical structures.
Results
Structure determination of the CD1d-PIM2 complex
Soluble mouse CD1d-␤ 2 M protein (residues 1-279 H chain and 1-99 ␤ 2 M) was expressed by Spodoptera frugiperda (SF9) cells and purified to homogeneity, as described in the methods section.
was loaded onto CD1d by incubation with a 7-fold molar excess of glycolipid without detergent. The CD1d-PIM2 complex was further purified from free lipid and protein aggregates by size exclusion chromatography. The CD1d-PIM2 complex was crystallized by sitting drop vapor diffusion and its three-dimensional structure determined by molecular replacement using the protein coordinates of the CD1d-sulfatide complex (PDB code 2AKR) as the search model (29) (Table I and Fig. 1 ). The crystal structure was refined to a final R cryst and R free of 21.1 and 27.6% respectively, with no outliers in the Ramachandran plot.
Structural features of the mouse CD1d-PIM2 complex
The overall architecture of mouse CD1d and its hydrophobic binding groove have previously been described in detail (18, 24, 42) . The bound PIM2 is remarkably ordered in the binding groove, despite its large carbohydrate headgroup that extends away from the surface of CD1d. The lipid backbone of PIM2 is accommodated inside the central cavity of CD1d, which is formed by two antiparallel ␣ helices that sit atop a six-stranded ␤-sheet platform. This cavity is lined mainly by hydrophobic residues (Fig. 2) , which stabilize the protein-lipid complex by extensive, nonpolar van der Waals' interactions. The two major pockets of the binding groove, designated AЈ and FЈ, are located deep inside CD1 and each accommodates one alkyl chain (C 16 in length) of the PIM2 ligand (Fig. 2) . The chemical structure of PIM2 is shown in Fig. 1B . Two mannose residues are linked to the inositol moiety of PI by ␣1-␣2 (2Ј-mannose) and ␣1-␣6 linkages (6Ј-mannose), respectively. The 2Ј mannose is less exposed and sits lower in the groove above the entrance to the AЈ pocket between the ␣1 and ␣2 helices. The 6Ј mannose projects away from the CD1 surface into the solvent, and suggests that the additional ␣1-␣6-linked mannose residues of the higher molecular mass ligands, such as PIM4, LM, or LAM, point away from the CD1 surface (Figs. 1-3A) . The bridging inositol is located close to the center of the binding groove between the interface of the AЈ and FЈ pockets. The phosphate group that links the lipid backbone to the sugar headgroup via the inositol is located next to Arg 79 , which can neutralize the negative charge of the glycolipid (Fig. 2) . The two identical alkyl chains of the glycerolipid backbone (palmitate, C 16:0 ) are attached to the sn1 and sn2 positions of the glycerol. The sn2-palmitate inserts into the FЈ pocket and makes an optimal fit. The sn1-palmitate fills most, but not all, of the larger AЈ pocket, where it initially follows a straight path to end up deep inside the pocket, and enabled the last five carbons to partially encircle the central pole (Phe 70 and Cys 12 ) in a clockwise orientation (Fig. 2) . This clockwise path is in contrast with all other reported crystal structures of either mouse or human CD1d (17-19, 24, 29) . However, this route allows the alkyl chain to form the maximal linear structure, which is more energetically favorable for alkyl chains of a certain size as the number of lower energy trans-rotamers can be optimized, before it has to encircle the pole.
In case of the natural Ag PIM4, the AЈ pocket would be occupied by the slightly longer (C 18 -CH 3 ) tuberculostearic acid, which carries an additional methyl group on C 10 . Modeling studies suggest that the extra methyl substituent can easily be accommodated in the wider AЈ pocket (Fig. 3B) . No spacer lipid was observed in the remainder of the pocket, as in other structures with shorter alkyl chains (C 8 -C 14 ) (17, 18) . This limited residual cavity in the AЈ pocket can only accommodate up to an additional C 10 alkyl chain. Free fatty acids of such length are not abundant in eukaryotic cells (43) .
Specific interactions between CD1d and PIM2
PIM2 has a more elaborate headgroup than the ligands of previously crystallized CD1d complexes and contains two additional mannoses that are connected by ␣1-2 and ␣1-6 linkages to the inositol of PI. Surprisingly, the entire headgroup is ordered in the crystal structure as a result of seven specific hydrogen bond interactions between CD1d and the polar groups of PIM2 (Fig. 4) . Among these CD1 residues, Asp 153 , Thr 156 , Arg 79 , and Ser 76 are also involved in stabilizing other CD1d ligands, such as shortchain ␣-GalCer, GalA-GSL, and sulfatide (17, 18, 29) but, in this case, Thr 159 confers additional specificity for the 2Ј-mannose of PIM2. Interestingly Asp 80 , which is usually important for defining the orientation of the sphingolipid backbone, due to formation of specific hydrogen bonds with the 3Ј-OH group of GalA-GSL and the 3Ј-OH and 4Ј-OH groups of ␣-GalCer, does not interact here with the carbonyl group of the sn2-linked palmitic acid. Arg 79 neutralizes the phosphate, while simultaneously stabilizing the 6Ј-mannose of PIM2 (Figs. 4 and 5A) . The phosphate is pulled toward the ␣1 helix by Arg 79 in such a way that the inositol flips back toward the ␣2 helix to interact with Asp 153 , while still remaining centered in the binding groove (Figs. 4 and 5A) .
Comparison of different CD1d ligands
The complex inositol-dimannoside headgroup of PIM2 extends from the center of the binding groove toward the N terminus of the ␣1 helix, so as to sit above the entrance to the AЈ pocket (Fig. 5A) . The headgroup is further aligned between Arg 79 and Asp 153 , similar to the situation with CD1d-sulfatide, in which the ␤-linked galactose is bound by Asp 153 in a similar general orientation to the inositol in PIM2 (Fig. 5B) . The 2Ј mannose sits above the entrance to the AЈ pocket, thereby blocking any access by the TCR to the underlying alkyl chain. This situation contrasts with the CD1d-sulfatide structure, in which the fatty acid chain is accessible for recognition by specific NKT cell TCRs. Such recognition was confirmed recently from a specific, sulfatide-restricted, NKT cell hybridoma that can distinguish between lysosulfatide (without any a Number in parentheses refers to the highest resolution shell. fatty acid) or sulfatide (with a C 16 -C 24 fatty acid) (29) . The headgroup of ␣-linked glycosphingolipids, such as short-chain ␣-GalCer (Fig. 5C) or GalA-GSL (data not shown) mainly interacts with the ␣2 helix, whereas the more complex PIM2 is bound in a completely different orientation (Fig. 5, A and D) , such that the 6Ј-mannose interacts closely with the ␣1 helix and the 2Ј-mannose is in a pocket between the ␣1 and ␣2 helices. Interestingly, all three ligands appear to activate V␣14 ϩ iNKT cells (12, 14, 15) . The overall binding of PIM2 and PC to CD1d is very different. Although the central, negatively charged phosphate of the two phosphoglycerolipids, is effectively neutralized by Arg 79 , PIM2 sits deeper in the CD1d binding groove and, in addition, is rotated 180°, compared with PC in the binding groove (Fig. 5E) . As a result, PIM2 inserts its sn1-fatty acid into the AЈ pocket and sn2-fatty acid into the FЈ pocket in contrast to the PC structure (24), FIGURE 2. Conformation of PIM2 in the CD1d binding groove. A side view is shown along the CD1d binding groove with the ␣2 helix removed for clarity. After excluding the ligand coordinates, a shake-omit map was calculated as a F o -F c electron density map as previously reported (21) and contoured at 2 as a blue mesh around the ligand (yellow). Several key contact residues that are involved in ligand binding are depicted and labeled. Note how Arg 79 (R79) is positioned to neutralize the negative charge of the phosphate group of PIM2. The alkyl chain at sn1 position of the glycerol (sn1) is inserted into the AЈ pocket of the binding groove, whereas the sn2-alkyl chain (sn2) fully fills the FЈ pocket. (56) for comparison. As the PIM2 phosphate has a pk a ϳ2, it is negatively charged in the crystal structure at pH 5.5 and at physiological pH. Carbon atoms 1 (sn1) and 2 (sn2) of glycerol that are esterified with fatty acyl moieties are indicated with the length of the individual alkyl chains given as the number of carbon atoms (C 16 palmitate acid; CH 3 -C 18 tuberculostearate). The linkages between the individual mannose residues (␣1-2 and ␣1-6) are labeled. Note that the natural tuberculostearic acid of PIM4 has a methyl substituent at carbon 10 of the sn1-linked fatty acid. The arrow in A indicates where the additional mannoses of PIM4 would be connected to PIM2.
where the sn1-fatty acid occupies the FЈ pocket. However, PIM2 cannot insert its sn1-fatty into the FЈ pocket as it sits deeper in the groove, due to the extra carbon of the glycerol, and would exceed the maximum length of C 16 that can optimally fit in this pocket. In the CD1d-PC structure, only a C 12 fatty acid was observed in the FЈ pocket. On the other hand, the CD1d residues that contact these disparate PIM2 and PC ligands adopt similar orientations. Next, we compared the binding of PIM2 as a glycerolipid to glycosphingolipids, such as sulfatide (Fig. 5F ). As expected, the additional phosphate group between the diacylglycerol backbone of PIM2 slightly raises the inositol-dimannoside headgroup above the binding groove, while it retains the same lateral disposition as the galactose of the sulfatide. The lipid backbones of these ligands do not superimpose well, mainly as a result of the different geometry of the glycerol in PIM2 vs the N-amide linkage of the fatty acid with the sphingosine of sulfatide or ␣-GalCer. In conclusion, three conserved polar interactions between the sphingolipid backbones of ␣-GalCer and sulfatide with CD1 residues Arg 79 , Asp 80 , and Thr 156 orient the glycosphingolipids in a similar manner to each other in the CD1d binding groove (17, 18, 29) , whereas the glycerolipid backbones of PC and PIM2 seem to be more flexible and differentially bound by CD1d. As a result, the five hydrogen bond interactions between PIM2 and CD1d (Fig. 4) dominate the binding orientation of the glycolipid in the CD1 binding groove and are responsible for the fine-positioning of the headgroup (Fig. 4) . 
Discussion
Tuberculosis is a global health threat, with a total of 3 billion infected people and 2 million attributed deaths each year (44) . Current vaccination strategies fail to protect adults effectively from pulmonary tuberculosis and the causative agent Mycobacterium tuberculosis is often unresponsive to many antibiotics due to its waxy and impenetrable cell envelope. Upon phagocytosis of the microbe by macrophages, cell wall lipids, such as PIMs and LAMs, are released into the lumen of phagosomes and subsequently trafficked into downstream endosomes and finally into lysosomes (45) . Along this route, these lipids can be detected by the immune system as they intersect with CD1 molecules (46) , which constantly survey the lipid content of APCs (47, 48) for subsequent activation of T cells. PIM4 was identified recently as an agonist of a subset of human and mouse NKT cells, when presented by CD1d (15) . CD1d tetramer-staining experiments show that only 0.26% of all mouse liver lymphocytes react to PIM4, while 32% of all liver lymphocytes can be stained with CD1d/␣-GalCer tetramers. However, 25% of ␣-GalCer reactive, mouse spleen NKT cells can be activated by PIM4 and subsequently secrete similar levels of IFN-␥ when compared with stimulation with ␣-GalCer. Nevertheless, given the limited quantity of PIM4 in mycobacterial cells walls, in comparison to PIM2 and PIM6 (49) , and the low number of activated NKT cells in mice, the biological relevance for PIM4 as a mouse NKT cell agonist requires further investigation.
Comparison of the binding and exposure of the various ligand headgroups in the CD1d binding groove allows several predictions to be made regarding interaction between ligand and its specific TCR. With the assumption that the iNKT cell TCR engagement to CD1 is somewhat akin to that of MHC class I/peptide/TCR (50, 51) , most of the recognition of the PIM2 core of the antigenic PIM4 will involve direct contacts with the invariant ␣-chain, particularly through the variable loop of the CDR 3 (CDR3␣) (Fig. 5) . This proposed interaction correlates strongly with the observed V␣14 restriction, whereas the TCR ␤-chain can vary without greatly compromising ligand recognition (11) . However, the ␤-chain, especially CDR3␤, would be ideally situated to interact with the additional two ␣1-6-linked mannose moieties in PIM4 and, hence, is likely to be involved in discrimination among the different PIM species (PIM2-PIM6).
NKT cells have an interspecies cross-reactivity, as mouse NKT cells can recognize ␣-GalCer when presented by mouse CD1d or human CD1d and vice versa. When the crystal structures of ␣-GalCer bound to either mouse or human CD1d are compared, it is apparent that the highly restricted iNKT cell TCR must have some plasticity that compensates for the slightly different presentation of ␣-GalCer in either species (52) . The crystal structures of four human V␣24 TCRs were recently determined (53, 54) and reveal a large surface cavity between the CDR3 loops of the ␣-and ␤-chains. Depending on the degree of TCR plasticity, this cavity could change in size and shape to accommodate the different headgroups of the CD1d ligands. In the case of PIM4 or iGb3, these changes must be substantial as their respective headgroups differ greatly in size (␣-GalCer, one sugar; iGb3, three sugars; and PIM4, four sugars and one inositol).
For CD1a and CD1b, the stability of the CD1-lipid complex was previously correlated with the extensive number of nonpolar van der Waals' interactions between the two alkyl chains of the glycolipid and the hydrophobic residues in the CD1 binding groove (lipid anchoring), rather than with specific hydrogen-bond interactions to the glycolipid headgroup (20 -23) . For mouse and human CD1d, all of the complex crystal structures so far have revealed a number of specific polar interactions and an extensive hydrogen-bond network between the headgroup and conserved CD1 residues that likely increase binding specificity and stability of the complex (17) (18) (19) 29) . In light of these findings, it seems plausible that, at least for PIMs, only one alkyl chain is necessary to recruit NKT cells (55) . The electron density of the CD1d-PIM2 complex structure reveals that the headgroup is much more ordered, compared with those in glycolipids or lipopeptides bound to CD1b or CD1a, respectively (20 -23) . Thus, we could speculate that, in addition to the observed lipid anchoring, the polar interaction between CD1d and the headgroup take on increasing importance for forming a stable glycolipid complex and in the finepositioning of the antigenic epitopes for TCR recognition, which could be of significance for development of novel immunomodulatory agents.
